Interview: Nadia Cortesi – Commercial Director, ResMed Italy

Nadia Cortesi, commercial director, ResMedHaving led a successful turnaround of the affiliate in just eight months, Nadia Cortesi of ResMed explains how she has achieved double digit growth, while facing sustained external challenges, including low awareness among consumers and healthcare authorities of the potential complications that sleep pathologies can cause. Can you please introduce yourself and ResMed’s footprint in Italy? When I joined ResMed four years ago the company was going through a tough time, not having grown in the three previous years. Thus, I had twelve months to understand the barriers to growth and implement a plan to turn the affiliate around. After examining the internal and external environment and diagnosing challenges in both, we implemented several changes to our internal structure, reassigning roles and responsibilities amongst our team. Just eight months after we made these changes the affiliate returned to growth, which is quite impressive.
The awareness of sleep apnea is alarmingly low. 70 to 80 percent of people are not diagnosed, which means there is a huge opportunity that is currently not being seized in terms of improving the quality of life for these patients.
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report